These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 19449222

  • 1. Isolated bone involvement of a single lumbar vertebra body as unusual presentation of relapsing Hodgkin's lymphoma.
    Niscola P, Tendas A, Scaramucci L, Fratoni S, Giovannini M, Ales M, Cupelli L, Natale G, Dentamaro T, De Fabritiis P.
    Acta Oncol; 2009; 48(7):1085-6. PubMed ID: 19449222
    [No Abstract] [Full Text] [Related]

  • 2. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R, Miller K, McCann J, Roitman D, Morelli J, Hurley C, Berkman E, Schenkein D.
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [Abstract] [Full Text] [Related]

  • 3. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.
    Phillips GL, Reece DE, Lerner KG, Connors JM.
    Bone Marrow Transplant; 1990 Jul; 6(1):45-7. PubMed ID: 1975204
    [Abstract] [Full Text] [Related]

  • 4. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A, Hardan I, Shpilberg O, Raanani P, Grotto I, Ben-Bassat I.
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.
    Brice P, Bouabdallah R, Moreau P, Divine M, André M, Aoudjane M, Fleury J, Anglaret B, Baruchel A, Sensebe L, Colombat P.
    Bone Marrow Transplant; 1997 Jul; 20(1):21-6. PubMed ID: 9232251
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [Abstract] [Full Text] [Related]

  • 9. Hodgkins disease in relapse presenting as bone tumor.
    Kumar S, Ferns SJ, Bhat BV, Patro DK.
    Indian Pediatr; 2003 Jan; 40(1):56-9. PubMed ID: 12554921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic strategies of Hodgkin's disease].
    Lathan B, Pfreundschuh M, Diehl V.
    Internist (Berl); 1993 Feb; 34(2):146-54. PubMed ID: 8454428
    [No Abstract] [Full Text] [Related]

  • 14. [Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Tacik J, Skoczeń S, Armata J, Balwierz W.
    Przegl Lek; 1992 Feb; 49(3):102-3. PubMed ID: 1438896
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB, Purugganan R, Fuller L, McLaughlin P, Swan F, Romaguera J, Rodriguez M, Cabanillas F.
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract] [Full Text] [Related]

  • 16. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
    Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
    [Abstract] [Full Text] [Related]

  • 17. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
    Subirà M, Sureda A, Martino R, García J, Altés A, Canals C, Domingo-Albós A, Brunet S, Sierra J.
    Haematologica; 2000 Feb; 85(2):167-72. PubMed ID: 10681724
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
    Glossmann JP, Josting A, Pfistner B, Paulus U, Engert A, German Hodgkin's Lymphoma Study Group (GHSG).
    Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
    [No Abstract] [Full Text] [Related]

  • 19. Hodgkin's disease presenting with osseous involvement.
    Chandra D, Ewton A, Baker K.
    Am J Hematol; 2006 Jul; 81(7):550-1. PubMed ID: 16755566
    [No Abstract] [Full Text] [Related]

  • 20. Skin involvement in Hodgkin's disease.
    Perifanis V, Sfikas G, Tziomalos K, Sotiriadis D, Garipidou V.
    Cancer Invest; 2006 Jul; 24(4):401-3. PubMed ID: 16777693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.